TTK Healthcare

37
Sell
  • Market Cap: Small Cap
  • Industry: Diversified
  • ISIN: INE910C01018
  • NSEID: TTKHLTCARE
  • BSEID: 507747
INR
1,088.95
-2 (-0.18%)
BSENSE

Dec 05

BSE+NSE Vol: 5.81 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 6.47% vs 3.82% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -6.70% vs 19.07% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 20.64% vs -47.40% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 29.94% vs 40.69% in Mar 2024

Compare Profit and Loss Results of TTK Healthcare
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
801.00
2,494.00
-1,693.00
-67.88%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
801.00
2,494.00
-1,693.00
-67.88%
Expenditure (Ex Depriciation)
Stock Adjustments
-13.00
-1.00
-12.00
-1,200.00%
Raw Materials Consumed
382.00
1,046.00
-664.00
-63.48%
Power & Fuel Cost
23.00
41.00
-18.00
-43.90%
Employee Cost
150.00
255.00
-105.00
-41.18%
Operating Expenses
37.00
660.00
-623.00
-94.39%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
134.00
68.00
66.00
97.06%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
85.00
-76.00
-89.41%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
766.00
2,197.00
-1,431.00
-65.13%
Operating Profit (PBDIT) excl Other Income
34.00
296.00
-262.00
-88.51%
Other Income
71.00
83.00
-12.00
-14.46%
Operating Profit (PBDIT)
106.00
379.00
-273.00
-72.03%
Interest
3.00
16.00
-13.00
-81.25%
Profit before Depriciation and Tax
102.00
363.00
-261.00
-71.90%
Depreciation
8.00
49.00
-41.00
-83.67%
Profit Before Taxation & Exceptional Items
94.00
313.00
-219.00
-69.97%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
108.00
313.00
-205.00
-65.50%
Provision for Tax
26.00
80.00
-54.00
-67.50%
Profit After Tax
81.00
232.00
-151.00
-65.09%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
874.00
949.00
-75.00
-7.90%
Profit Available for appropriations
956.00
1,182.00
-226.00
-19.12%
Appropriations
956.00
1,182.00
-226.00
-19.12%
Equity Dividend (%)
100%
85%
15.00
Earnings Per Share
57.79
13.61
44.18
324.61%
Profit And Loss - Net Sales
Net Sales 801.49 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.47% vs 3.82% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 34.83 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -6.70% vs 19.07% in Mar 2024

Profit And Loss - Interest
Interest 3.32 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 20.64% vs -47.40% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 81.66 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 29.94% vs 40.69% in Mar 2024